Resources
The AMA has collected more than 400 educational and other resources to provide evidence-based recommendations for physicians and policymakers.
The AMA has collected more than 400 educational and other resources to provide evidence-based recommendations for physicians and policymakers.
This issue brief seeks to dispel myths and provide practical strategies to save lives and reduce harms from drug-related overdose.
The first of three issue briefs to encourage meaningful state and federal enforcement of mental health and substance use disorder parity laws.
Added 11/8/23
Added 11/8/23
Added 11/8/23
Added 11/8/23
Updated January 2023
From 2012 to 2021, medications to treat opioid use disorder (MOUD) increased 104%; from 2020 to 2021, however, it only increased 1.6%.
From 2016 to 2021, naloxone prescriptions dispensed from pharmacies increased from almost 134,000 to nearly 1.2 million prescriptions.
From 2012 to 2021, every state in the nation saw a large decrease of prescription opioids dispensed from retail pharmacies.
Physicians and other authorized users queried state prescription drug monitoring programs (PDMPs) more than 1.1 billion times in 2021
This issue brief provides a one-page overview of the epidemic and select AMA advocacy initiatives and resources.
The AMA Substance Use and Pain Care Task Force urges physicians and other health care professions to continue taking action to help reverse the nation’s drug overdose epidemic—and the Task Force also calls on policymakers to take specific steps to remove barriers to evidence-based care for patients with pain and those with a substance use disorder.
Learn More Join the AMA today and help us lead the effort
to reverse the nation’s opioid epidemic.